Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN Retraction in /10.3892/mmr.2022.12831

Wei,Dongdong; Miao,Yingbin; Yu,Lianxia; Wang,Degong; Wang,Yingli

doi:10.3892/mmr.2018.8979

Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN

Retraction in: /10.3892/mmr.2022.12831

Authors:
- Dongdong Wei
- Yingbin Miao
- Lianxia Yu
- Degong Wang
- Yingli Wang
View Affiliations

Affiliations: Department of Ophthalmology, Dezhou People's Hospital, Dezhou, Shandong 253000, P.R. China, Department of Ophthalmology, The Second People Hospital of Dezhou, Dezhou, Shandong 253024, P.R. China, Department of Ophthalmology, Yantai Yeda Hospital, Yantai, Shandong 264006, P.R. China
Published online on: May 7, 2018 https://doi.org/10.3892/mmr.2018.8979
Pages: 595-602

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A number of studies have highlighted that aberrantly expressed microRNAs (miRNAs/miRs) serve crucial roles in the tumorigenesis and tumor development of retinoblastoma (RB). Hence, a full investigation of the biological roles and regulatory mechanisms of miRNAs in RB may provide novel therapeutic targets for patients with this malignancy. miR‑198 is frequently abnormally expressed in various types of human cancers. However, the expression level, biological roles and underlying mechanisms of miR‑198 in RB remain to be elucidated. In the present study, miR‑198 expression was upregulated in RB tissues and cell lines. Silencing of miR‑198 attenuated cell proliferation and invasion in RB. In addition, phosphatase and tensin homolog deleted on chromosome ten (PTEN) was predicted as a potential target of miR‑198 using bioinformatics analysis. Subsequent luciferase reporter assay indicated that the 3'‑untranslated region of PTEN can be directly targeted by miR‑198. Furthermore, miR‑198 inhibition increased the PTEN expression at the mRNA and protein levels in RB cells. In addition, PTEN mRNA expression was downregulated in RB tissues, and this downregulation was inversely associated with the expression level of miR‑198. PTEN knockdown rescued the inhibitory effects of miR‑198 underexpression on cell proliferation and invasion in RB. Notably, the downregulation of miR‑198 inactivated the phosphoinositide 3‑kinase (PI3K)/protein kinase B (AKT) signaling pathway in RB. These results demonstrated that miR‑198 may serve oncogenic roles in RB by directly targeting PTEN and regulating the PI3K/AKT signaling pathway. Hence, miR‑198 may be a promising therapeutic target for patients with RB.

View Figures

View References

1	Dimaras H, Kimani K, Dimba EA, Gronsdahl P, Whit A, Chan HS and Gallie BL: Retinoblastoma. Lancet. 379:1436–1446. 2012. View Article : Google Scholar : PubMed/NCBI
2	Kivelä T: The epidemiological challenge of the most frequent eye cancer: Retinoblastoma, an issue of birth and death. Br J Ophthalmol. 93:1129–1131. 2009. View Article : Google Scholar : PubMed/NCBI
3	Abramson DH, Beaverson K, Sangani P, Vora RA, Lee TC, Hochberg HM, Kirszrot J and Ranjithan M: Screening for retinoblastoma: Presenting signs as prognosticators of patient and ocular survival. Pediatrics. 112:1248–1255. 2003. View Article : Google Scholar : PubMed/NCBI
4	Balmer A, Zografos L and Munier F: Diagnosis and current management of retinoblastoma. Oncogene. 25:5341–5349. 2006. View Article : Google Scholar : PubMed/NCBI
5	Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG and Shields C: Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 10:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
7	Moss EG: MicroRNAs: Hidden in the genome. Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
8	Kozomara A and Griffiths-Jones S: miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39:(Database Issue). D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
9	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
10	Golabchi K, Soleimani-Jelodar R, Aghadoost N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H and Mirzaei H: MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers. J Cell Physiol. 233:3016–3023. 2018. View Article : Google Scholar : PubMed/NCBI
11	Liu B, Chen W, Cao G, Dong Z, Xu J, Luo T and Zhang S: MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway. Arch Oral Biol. 83:92–96. 2017. View Article : Google Scholar : PubMed/NCBI
12	Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z and Lu M: Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer. Onco Targets Ther. 10:5711–5718. 2017. View Article : Google Scholar : PubMed/NCBI
13	Sun X, Wang M, Liu H and Wang J: MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1. Am J Transl Res. 9:5576–5584. 2017.PubMed/NCBI
14	D'Angelo B, Benedetti E, Cimini A and Giordano A: MicroRNAs: A puzzling tool in cancer diagnostics and therapy. Anticancer Res. 36:5571–5575. 2016. View Article : Google Scholar : PubMed/NCBI
15	Hu Y, Tang Z, Jiang B, Chen J and Fu Z: miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1. Oncol Lett. 13:1753–1760. 2017. View Article : Google Scholar : PubMed/NCBI
16	Nie E, Jin X, Wu W, Yu T, Zhou X, Shi Z, Zhang J, Liu N and You Y: MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT. J Neurooncol. 133:59–68. 2017. View Article : Google Scholar : PubMed/NCBI
17	Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G and Dang YW: Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: A clinicopathological and in silico study. Onco Targets Ther. 9:5163–5180. 2016. View Article : Google Scholar : PubMed/NCBI
18	Zhang S, Zhao Y and Wang L: MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Zou WW and Xu SP: Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and Caspase-3 pathways in retinoblastoma. Biomed Pharmacother. 97:851–863. 2018. View Article : Google Scholar : PubMed/NCBI
21	Gui F, Hong Z, You Z, Wu H and Zhang Y: MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway. Cell Biol Int. 40:1294–1302. 2016. View Article : Google Scholar : PubMed/NCBI
22	Liu Y, Wan ST, Zhang P, Zhang WX, Zheng JL, Lin JX and Li YP: Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. Int J Ophthalmol. 7:594–601. 2014.PubMed/NCBI
23	Liang Y, Chen X and Liang Z: MicroRNA-320 regulates autophagy in retinoblastoma by targeting hypoxia inducible factor-1α. Exp Ther Med. 14:2367–2372. 2017. View Article : Google Scholar : PubMed/NCBI
24	Wang LL, Hu HF and Feng YQ: Suppressive effect of microRNA-143 in retinoblastoma. Int J Ophthalmol. 9:1584–1590. 2016.PubMed/NCBI
25	Bai S, Tian B, Li A, Yao Q, Zhang G and Li F: MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma. Eye (Lond). 30:1630–1638. 2016. View Article : Google Scholar : PubMed/NCBI
26	Yang J, Zhao H, Xin Y and Fan L: MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ye L, Li S, Ye D, Yang D, Yue F, Guo Y, Chen X, Chen F, Zhang J and Song X: Livin expression may be regulated by miR-198 in human prostate cancer cell lines. Eur J Cancer. 49:734–740. 2013. View Article : Google Scholar : PubMed/NCBI
28	Qi B, Yao WJ, Zhao BS, Qin XG, Wang Y, Wang WJ, Wang TY, Liu SG and Li HC: Involvement of microRNA-198 overexpression in the poor prognosis of esophageal cancer. Asian Pac J Cancer Prev. 14:5073–5076. 2013. View Article : Google Scholar : PubMed/NCBI
29	Tan S, Li R, Ding K, Lobie PE and Zhu T: miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett. 585:2229–2234. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wu S, Zhang G, Li P, Chen S, Zhang F, Li J, Jiang C, Chen X, Wang Y, Du Y, et al: miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma. Tumour Biol. 37:5193–5202. 2016. View Article : Google Scholar : PubMed/NCBI
31	Wang J, Dan G, Shangguan T, Hao H, Tang R, Peng K, Zhao J, Sun H and Zou Z: miR-198 represses the proliferation of HaCaT cells by targeting cyclin D2. Int J Mol Sci. 16:17018–17028. 2015. View Article : Google Scholar : PubMed/NCBI
32	Fei G, Ebert MP, Mawrin C, Leodolter A, Schmidt N, Dietzmann K and Malfertheiner P: Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives. Eur J Gastroenterol Hepatol. 14:297–303. 2002. View Article : Google Scholar : PubMed/NCBI
33	Koksal IT, Yasar D, Dirice E, Usta MF, Karauzum S, Luleci G, Baykara M and Sanlioglu S: Differential PTEN protein expression profiles in superficial versus invasive bladder cancers. Urol Int. 75:102–106. 2005. View Article : Google Scholar : PubMed/NCBI
34	Loures LF, Cândido EB, Vidigal PV, Seabra MA, Marco LA and Silva-Filho AL: PTEN expression in patients with carcinoma of the cervix and its association with p53, Ki-67 and CD31. Rev Bras Ginecol Obstet. 36:205–210. 2014. View Article : Google Scholar : PubMed/NCBI
35	Li Y, Li Y, Yang H and Wang P: Expressions and significance of PTEN and LKB1 in non-small cell lung cancer. Sichuan Da Xue Xue Bao Yi Xue Ban. 47:507–511. 2016.PubMed/NCBI
36	de Araujo WM, Robbs BK, Bastos LG, de Souza WF, Vidal FC, Viola JP and Morgado-Diaz JA: PTEN overexpression cooperates with lithium to reduce the malignancy and to increase cell death by apoptosis via PI3K/Akt suppression in colorectal cancer cells. J Cell Biochem. 117:458–469. 2016. View Article : Google Scholar : PubMed/NCBI
37	Liu H, Pan Y, Han X, Liu J and Li R: MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway. Onco Targets Ther. 10:2701–2709. 2017. View Article : Google Scholar : PubMed/NCBI
38	Koul D, Shen R, Garyali A, Ke LD, Liu TJ and Yung WK: MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol. 21:469–475. 2002.PubMed/NCBI
39	Tao J, Xiong J, Li T, Yang Z, Li X, Li K, Wu H and Wang C: Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis. J Huazhong Univ Sci Technolog Med Sci. 26:444–447. 2006. View Article : Google Scholar : PubMed/NCBI